Because IFNAR1 mediates all isoforms of IFN-I signaling, our above findings suggest that human colon carcinoma might use down-regulating IFNAR1 to impair IFN-I signaling in CTLs to evade immune surveillance. This evidence concerns the gene IFNAR1 and colon carcinoma.